Annual Operating Profit
-$15.94 M
-$5.02 M-46.02%
31 December 2023
Summary:
Trinity Biotech annual operaing income is currently -$15.94 million, with the most recent change of -$5.02 million (-46.02%) on 31 December 2023. During the last 3 years, it has fallen by -$33.80 million (-189.26%). TRIB annual operating profit is now -189.26% below its all-time high of $17.86 million, reached on 31 December 2020.TRIB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$2.22 M
-$552.00 K-33.11%
30 September 2024
Summary:
Trinity Biotech quarterly operating income is currently -$2.22 million, with the most recent change of -$552.00 thousand (-33.11%) on 30 September 2024. Over the past year, it has increased by +$2.28 million (+50.69%). TRIB quarterly operating profit is now -106.39% below its all-time high of $34.73 million, reached on 30 September 2007.TRIB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$10.41 M
+$2.28 M+17.97%
30 September 2024
Summary:
Trinity Biotech TTM operating income is currently -$10.41 million, with the most recent change of +$2.28 million (+17.97%) on 30 September 2024. Over the past year, it has increased by +$7.17 million (+40.78%). TRIB TTM operating profit is now -124.30% below its all-time high of $42.87 million, reached on 30 September 2007.TRIB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.0% | +50.7% | +40.8% |
| 3 y3 years | -189.3% | -180.2% | -155.7% |
| 5 y5 years | -337.7% | -266.5% | -279.7% |
TRIB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -189.3% | at low | -180.2% | +62.0% | -155.7% | +45.0% |
| 5 y | 5 years | -189.3% | at low | -124.4% | +62.0% | -141.6% | +45.0% |
| alltime | all time | -189.3% | +46.5% | -106.4% | +98.7% | -124.3% | +93.8% |
Trinity Biotech Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.22 M(+33.1%) | -$10.41 M(-18.0%) |
| June 2024 | - | -$1.67 M(-45.2%) | -$12.70 M(-15.7%) |
| Mar 2024 | - | -$3.04 M(-12.8%) | -$15.07 M(-5.5%) |
| Dec 2023 | -$15.94 M(+46.0%) | -$3.49 M(-22.5%) | -$15.94 M(-9.3%) |
| Sept 2023 | - | -$4.50 M(+11.5%) | -$17.59 M(-7.1%) |
| June 2023 | - | -$4.04 M(+3.0%) | -$18.93 M(+16.7%) |
| Mar 2023 | - | -$3.92 M(-23.6%) | -$16.23 M(+20.0%) |
| Dec 2022 | -$10.92 M(-180.5%) | -$5.13 M(-12.2%) | -$13.52 M(-3.9%) |
| Sept 2022 | - | -$5.84 M(+339.0%) | -$14.07 M(+157.8%) |
| June 2022 | - | -$1.33 M(+9.5%) | -$5.46 M(-352.6%) |
| Mar 2022 | - | -$1.22 M(-78.6%) | $2.16 M(-66.5%) |
| Dec 2021 | $13.56 M(-24.0%) | -$5.68 M(-305.1%) | $6.45 M(-65.5%) |
| Sept 2021 | - | $2.77 M(-56.0%) | $18.71 M(-25.2%) |
| June 2021 | - | $6.29 M(+104.2%) | $25.03 M(+30.1%) |
| Mar 2021 | - | $3.08 M(-53.2%) | $19.24 M(+7.8%) |
| Dec 2020 | $17.86 M(+9821.1%) | $6.58 M(-27.6%) | $17.86 M(+134.9%) |
| Sept 2020 | - | $9.09 M(+1713.4%) | $7.60 M(-5202.7%) |
| June 2020 | - | $501.00 K(-70.4%) | -$149.00 K(-126.8%) |
| Mar 2020 | - | $1.69 M(-146.1%) | $555.00 K(+204.9%) |
| Dec 2019 | $180.00 K(-97.3%) | -$3.68 M(-375.8%) | $182.00 K(-96.9%) |
| Sept 2019 | - | $1.33 M(+10.6%) | $5.80 M(+1.7%) |
| June 2019 | - | $1.21 M(-8.7%) | $5.70 M(-8.4%) |
| Mar 2019 | - | $1.32 M(-31.9%) | $6.22 M(-7.2%) |
| Dec 2018 | $6.71 M(+64.1%) | $1.94 M(+56.8%) | $6.71 M(+60.2%) |
| Sept 2018 | - | $1.24 M(-28.4%) | $4.19 M(-6.5%) |
| June 2018 | - | $1.73 M(-4.4%) | $4.48 M(-2.3%) |
| Mar 2018 | - | $1.81 M(-410.8%) | $4.58 M(+12.2%) |
| Dec 2017 | $4.09 M(-50.0%) | -$581.00 K(-138.0%) | $4.09 M(-22.3%) |
| Sept 2017 | - | $1.53 M(-16.6%) | $5.26 M(-18.4%) |
| June 2017 | - | $1.83 M(+40.1%) | $6.45 M(-7.5%) |
| Mar 2017 | - | $1.31 M(+120.6%) | $6.97 M(-6.9%) |
| Dec 2016 | $8.18 M(-38.5%) | $593.00 K(-78.2%) | $7.49 M(-25.3%) |
| Sept 2016 | - | $2.72 M(+15.4%) | $10.03 M(-2.5%) |
| June 2016 | - | $2.36 M(+29.1%) | $10.28 M(-6.0%) |
| Mar 2016 | - | $1.82 M(-41.7%) | $10.94 M(-18.7%) |
| Dec 2015 | $13.30 M(-12.4%) | $3.13 M(+5.4%) | $13.45 M(+14.3%) |
| Sept 2015 | - | $2.97 M(-1.3%) | $11.76 M(-12.4%) |
| June 2015 | - | $3.01 M(-30.6%) | $13.43 M(-10.5%) |
| Mar 2015 | - | $4.33 M(+200.2%) | $15.02 M(-1.1%) |
| Dec 2014 | $15.19 M(+73.7%) | $1.44 M(-68.9%) | $15.18 M(+49.7%) |
| Sept 2014 | - | $4.64 M(+1.1%) | $10.14 M(-1.4%) |
| June 2014 | - | $4.59 M(+2.0%) | $10.29 M(+9.9%) |
| Mar 2014 | - | $4.50 M(-225.1%) | $9.36 M(+7.0%) |
| Dec 2013 | $8.74 M(-48.3%) | -$3.60 M(-175.2%) | $8.74 M(-47.0%) |
| Sept 2013 | - | $4.79 M(+30.6%) | $16.49 M(+2.7%) |
| June 2013 | - | $3.67 M(-5.8%) | $16.05 M(-3.8%) |
| Mar 2013 | - | $3.89 M(-6.2%) | $16.68 M(-1.4%) |
| Dec 2012 | $16.92 M(+8.9%) | $4.15 M(-4.7%) | $16.92 M(-2.5%) |
| Sept 2012 | - | $4.35 M(+1.2%) | $17.35 M(+2.6%) |
| June 2012 | - | $4.30 M(+4.0%) | $16.91 M(+2.5%) |
| Mar 2012 | - | $4.13 M(-9.6%) | $16.50 M(+4.6%) |
| Dec 2011 | $15.54 M(+12.5%) | $4.57 M(+17.0%) | $15.77 M(+8.3%) |
| Sept 2011 | - | $3.91 M(+0.5%) | $14.56 M(+4.6%) |
| June 2011 | - | $3.89 M(+14.3%) | $13.92 M(+7.0%) |
| Mar 2011 | - | $3.40 M(+1.1%) | $13.02 M(-1.6%) |
| Dec 2010 | $13.82 M(+1.1%) | $3.36 M(+3.0%) | $13.23 M(-0.7%) |
| Sept 2010 | - | $3.27 M(+9.6%) | $13.33 M(-2.4%) |
| June 2010 | - | $2.98 M(-17.6%) | $13.65 M(-5.5%) |
| Mar 2010 | - | $3.62 M(+4.5%) | $14.44 M(+4.2%) |
| Dec 2009 | $13.66 M(+64.5%) | $3.46 M(-3.5%) | $13.87 M(+10.0%) |
| Sept 2009 | - | $3.59 M(-4.9%) | $12.60 M(+14.3%) |
| June 2009 | - | $3.77 M(+24.0%) | $11.03 M(+16.5%) |
| Mar 2009 | - | $3.04 M(+38.2%) | $9.47 M(+15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | $8.31 M(-127.9%) | $2.20 M(+9.3%) | $8.21 M(-104.9%) |
| Sept 2008 | - | $2.01 M(-9.0%) | -$167.39 M(+24.3%) |
| June 2008 | - | $2.21 M(+24.3%) | -$134.67 M(+1.1%) |
| Mar 2008 | - | $1.78 M(-101.0%) | -$133.19 M(+1.2%) |
| Dec 2007 | -$29.79 M(-1634.5%) | -$173.40 M(-599.2%) | -$131.66 M(-407.1%) |
| Sept 2007 | - | $34.73 M(+839.3%) | $42.87 M(+286.6%) |
| June 2007 | - | $3.70 M(+11.7%) | $11.09 M(+202.3%) |
| Mar 2007 | - | $3.31 M(+195.5%) | $3.67 M(+88.9%) |
| Dec 2006 | $1.94 M(-70.7%) | $1.12 M(-62.1%) | $1.94 M(-39.5%) |
| Sept 2006 | - | $2.96 M(-179.5%) | $3.21 M(+53.5%) |
| June 2006 | - | -$3.72 M(-334.7%) | $2.09 M(-70.8%) |
| Mar 2006 | - | $1.59 M(-33.6%) | $7.15 M(+2.1%) |
| Dec 2005 | $6.62 M(+12.4%) | $2.39 M(+29.7%) | $7.00 M(+7.5%) |
| Sept 2005 | - | $1.84 M(+37.9%) | $6.51 M(+1.3%) |
| June 2005 | - | $1.33 M(-7.2%) | $6.43 M(-1.0%) |
| Mar 2005 | - | $1.44 M(-24.2%) | $6.49 M(+10.2%) |
| Dec 2004 | $5.89 M(-39.1%) | $1.90 M(+8.1%) | $5.89 M(-14.0%) |
| Sept 2004 | - | $1.76 M(+25.4%) | $6.85 M(-8.4%) |
| June 2004 | - | $1.40 M(+66.9%) | $7.48 M(-9.7%) |
| Mar 2004 | - | $839.00 K(-70.6%) | $8.29 M(-14.3%) |
| Dec 2003 | $9.67 M(+48.2%) | $2.86 M(+19.9%) | $9.67 M(+14.2%) |
| Sept 2003 | - | $2.38 M(+8.1%) | $8.47 M(+9.1%) |
| June 2003 | - | $2.21 M(-0.8%) | $7.76 M(+7.8%) |
| Mar 2003 | - | $2.22 M(+34.2%) | $7.20 M(+10.3%) |
| Dec 2002 | $6.52 M(+12.2%) | $1.66 M(-1.4%) | $6.52 M(-6.6%) |
| Sept 2002 | - | $1.68 M(+2.4%) | $6.99 M(+4.4%) |
| June 2002 | - | $1.64 M(+5.9%) | $6.70 M(+7.9%) |
| Mar 2002 | - | $1.55 M(-26.9%) | $6.20 M(+6.7%) |
| Dec 2001 | $5.82 M(-10.6%) | $2.12 M(+52.8%) | $5.82 M(+7.8%) |
| Sept 2001 | - | $1.39 M(+20.7%) | $5.39 M(-5.9%) |
| June 2001 | - | $1.15 M(-0.9%) | $5.73 M(-6.9%) |
| Mar 2001 | - | $1.16 M(-31.7%) | $6.16 M(-5.4%) |
| Dec 2000 | $6.50 M(+25.9%) | $1.70 M(-1.6%) | $6.50 M(+3.0%) |
| Sept 2000 | - | $1.73 M(+9.9%) | $6.32 M(+5.4%) |
| June 2000 | - | $1.57 M(+4.1%) | $5.99 M(+6.6%) |
| Mar 2000 | - | $1.51 M(-0.2%) | $5.62 M(+6.8%) |
| Dec 1999 | $5.17 M(+80.0%) | $1.51 M(+7.8%) | $5.27 M(+11.5%) |
| Sept 1999 | - | $1.40 M(+16.6%) | $4.72 M(+17.5%) |
| June 1999 | - | $1.20 M(+4.5%) | $4.02 M(+21.1%) |
| Mar 1999 | - | $1.15 M(+18.6%) | $3.32 M(-56.7%) |
| Dec 1998 | $2.87 M(+474.0%) | $970.00 K(+38.6%) | $7.67 M(-253.4%) |
| Sept 1998 | - | $700.00 K(+40.0%) | -$5.00 M(+614.3%) |
| June 1998 | - | $500.00 K(-90.9%) | -$700.00 K(-124.1%) |
| Mar 1998 | - | $5.50 M(-147.0%) | $2.90 M(+480.0%) |
| Dec 1997 | $500.00 K(-171.4%) | -$11.70 M(-334.0%) | $500.00 K(-92.4%) |
| Sept 1997 | - | $5.00 M(+22.0%) | $6.60 M(+88.6%) |
| June 1997 | - | $4.10 M(+32.3%) | $3.50 M(+288.9%) |
| Mar 1997 | - | $3.10 M(-155.4%) | $900.00 K(-228.6%) |
| Dec 1996 | -$700.00 K(-61.1%) | -$5.60 M(-394.7%) | -$700.00 K(-83.7%) |
| Sept 1996 | - | $1.90 M(+26.7%) | -$4.30 M(+16.2%) |
| June 1996 | - | $1.50 M(0.0%) | -$3.70 M(+32.1%) |
| Mar 1996 | - | $1.50 M(-116.3%) | -$2.80 M(+55.6%) |
| Dec 1995 | -$1.80 M(-33.3%) | -$9.20 M(-468.0%) | -$1.80 M(-124.3%) |
| Sept 1995 | - | $2.50 M(+4.2%) | $7.40 M(+12.1%) |
| June 1995 | - | $2.40 M(-4.0%) | $6.60 M(+11.9%) |
| Mar 1995 | - | $2.50 M(+47.1%) | $5.90 M(-395.0%) |
| Dec 1994 | -$2.70 M(-35.7%) | - | - |
| Aug 1994 | - | $1.70 M(0.0%) | -$2.00 M(-35.5%) |
| May 1994 | - | $1.70 M(-128.3%) | -$3.10 M(-26.2%) |
| Feb 1994 | - | -$6.00 M(-1100.0%) | -$4.20 M(-333.3%) |
| Feb 1994 | -$4.20 M | - | - |
| Nov 1993 | - | $600.00 K(0.0%) | $1.80 M(+50.0%) |
| Aug 1993 | - | $600.00 K(0.0%) | $1.20 M(+100.0%) |
| May 1993 | - | $600.00 K | $600.00 K |
FAQ
- What is Trinity Biotech annual operaing income?
- What is the all time high annual operating profit for Trinity Biotech?
- What is Trinity Biotech annual operating profit year-on-year change?
- What is Trinity Biotech quarterly operating income?
- What is the all time high quarterly operating profit for Trinity Biotech?
- What is Trinity Biotech quarterly operating profit year-on-year change?
- What is Trinity Biotech TTM operating income?
- What is the all time high TTM operating profit for Trinity Biotech?
- What is Trinity Biotech TTM operating profit year-on-year change?
What is Trinity Biotech annual operaing income?
The current annual operating profit of TRIB is -$15.94 M
What is the all time high annual operating profit for Trinity Biotech?
Trinity Biotech all-time high annual operaing income is $17.86 M
What is Trinity Biotech annual operating profit year-on-year change?
Over the past year, TRIB annual operaing income has changed by -$5.02 M (-46.02%)
What is Trinity Biotech quarterly operating income?
The current quarterly operating profit of TRIB is -$2.22 M
What is the all time high quarterly operating profit for Trinity Biotech?
Trinity Biotech all-time high quarterly operating income is $34.73 M
What is Trinity Biotech quarterly operating profit year-on-year change?
Over the past year, TRIB quarterly operating income has changed by +$2.28 M (+50.69%)
What is Trinity Biotech TTM operating income?
The current TTM operating profit of TRIB is -$10.41 M
What is the all time high TTM operating profit for Trinity Biotech?
Trinity Biotech all-time high TTM operating income is $42.87 M
What is Trinity Biotech TTM operating profit year-on-year change?
Over the past year, TRIB TTM operating income has changed by +$7.17 M (+40.78%)